Minimal residual disease: optimal methods, timing, and clinical relevance for an individual patient.

Hematology / the Education Program of the American Society of Hematology. American Society of Hematology. Education Program

Volumn 2012, Issue , 2012, Pages 137-142

  Schrappe, Martin ^a  

^a UNIVERSITY OF KIEL   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

RNA;

ACUTE LYMPHOBLASTIC LEUKEMIA; FLOW CYTOMETRY; GENE EXPRESSION REGULATION; GENE REARRANGEMENT; GENETICS; HUMAN; IMMUNOGLOBULIN GENE; IMMUNOPHENOTYPING; METHODOLOGY; MINIMAL RESIDUAL DISEASE; PROGNOSIS; RECURRENT DISEASE; REVIEW; RISK; TREATMENT OUTCOME;

FLOW CYTOMETRY; GENE EXPRESSION REGULATION, LEUKEMIC; GENE REARRANGEMENT; GENE REARRANGEMENT, T-LYMPHOCYTE; GENES, IMMUNOGLOBULIN; HUMANS; IMMUNOPHENOTYPING; NEOPLASM, RESIDUAL; PRECURSOR CELL LYMPHOBLASTIC LEUKEMIA-LYMPHOMA; PROGNOSIS; RECURRENCE; RISK; RNA, NEOPLASM; TREATMENT OUTCOME;

MLCS; MLOWN;

EID: 84879257040     PISSN: None     EISSN: 15204383     Source Type: Journal    
DOI: 10.1182/asheducation.v2012.1.137.3798216     Document Type: Review

References (0)